Innovative Injection for Fat Cell Removal
Initial clinical trials have shown that the treatment "CBL-514" represents a potential breakthrough in obesity treatment, as it stimulates fat cells to undergo safe self-destruction rather than merely reducing their size. The study indicated that participants who received injections over a 12-week period lost approximately 12% of visceral fat, while in the control group, its volume increased by 5.68%. In addition to cosmetic benefits, the treatment improves blood pressure and cholesterol levels, with its effectiveness potentially doubled when combined with medications like tirzepatide. It also effectively prevents fat regain after stopping common treatments, as it completely eliminates fat cells. The research teams are currently conducting larger studies to verify its long-term efficacy and safety.
Notice: This Is an AI-Generated Summary
Comments (0)